How CHIPSA Treats Squamous Cell Carcinoma Patients
Did you know Squamous cell carcinoma is the most common head and neck cancer?
Approximately 90% of head and neck cancers are Squamous cell carcinoma. This occurs in the outer layer of the skin and certain tissues of the head and neck. This can include the sinuses, nose, throat and mouth.
Squamous cell carcinoma of the head and neck should be treated as soon as possible to give the patient the best chance of long term survival.
Characterizing the different types of squamous cell cancer is important in formulating a treatment approach.
There are generally four distinct types of squamous cell carcinoma:
- HPV related squamous cell without smoking
- HPV related squamous cell with smoking
- Non-HPV related squamous cell without smoking or nicotine
- Non- HPBV related squamous cell with smoking or nicotine.
The most common regions that squamous cell occur are:
- Squamous cell carcinoma of the paranasal sinuses and nasal cavity
- Nasopharyngeal squamous cell carcinoma
- Squamous cell carcinoma of the throat (oropharyngeal)
- Squamous cell carcinoma of the mouth (oral cavity)
- Squamous cell carcinoma of the voice box (laryngeal)
Common symptoms include the following:
- Pain or difficulty swallowing
- Sore throat
- Voice changes
- Lump on throat
- Ear ache
- Mass on neck
CHIPSA’s Treatment of Squamous Cell Carcinoma
CHIPSA has treated numerous squamous cell patients over the years and learned a lot from our experience.
Unfortunately many patients come to us after their tumor has grown very big and their oncologist at home has told them there’s nothing more that can be done.
Treatment strategy of squamous cell carcinoma depends on a number of factors. Over the years our treatment approach has evolved due to the quick response we generally get with this cancer. Our team learned that most patients treated at CHIPSA with squamous cell cancer would have their tumor shrink quickly. While this was impressive the cancer would later come back if the patient wasn’t able to continue immunotherapy treatments at home.
The following cases are of patients that were told by their oncologist that there was nothing more that could be done and that they only had months to live.
John’s Story
John D. came to CHIPSA with stage 4 squamous cell carcinoma of the neck. His tumor was around 10cm in size and over 3cm thick when he arrived at CHIPSA. It spread throughout his throat all the way around to the other side of his neck. John was given weeks to live.
John started treatment at CHIPSA and had his tumor completely disappear within 8 weeks. It was incredible to watch because we were concerned on his arrival that he could pass away at the hospital.
When he went back home he was not able to stay on the protocol at home and his cancer returned. He came back to CHIPSA a second time and again his cancer disappeared.
Sadly John was not able to return to CHIPSA the third time it came back. His oncologist at home was not allowed to work with our therapies and he passed away.
While losing John was very sad, he and his family became very close with our team. They wanted his story shared with the world because John lived years longer than the months his originally given. John lived without harmful side effects and with a good quality of life that he enjoyed with his family.
Sam’s SCC Story
Sam B. was diagnosed with squamous cell carcinoma in December of 2015. His cancer unfortunately did not respond well to treatments and he was given a short time to live.
Sam went to 3 other clinics in Mexico before coming to CHIPSA. Sadly his tumor did not respond at any of these clinics.
After his wife saw before and after photos of of other SCC patients from CHIPSA, she encouraged Sam to call. Before his arrival, Sam was experiencing extreme pain due to his enlarged tumor on his neck.
This is his tumor days before he arrived at CHIPSA.
After three weeks of treatment at CHIPSA, Sam saw a dramatic decrease in the size of his tumor.
Not only did Sam see a physical shrinkage of his tumor on the outside, he also saw a reduction of the tumors he had inside. Sam also had tumors in the roof of his mouth, on the back of his uvula, down his throat, on the side of his tongue, in his sinuses, and ear. All his tumors had great reductions.
Sam returned to CHIPSA after a recurrence in February of 2021. Adjustments were made to his treatment protocol and as of 2/2022 he has no evidence of squamous cell carcinoma.
Willy’s SCC Story
Willy F. was diagnosed with indifferent nasopharyngeal carcinoma, a form of SCC, at the young age of 33. This version of squamous cell carcinoma, which is caused by a virus, is particularly aggressive. At the time of his diagnosis, his tumor had spread and taken over his entire neck. Four years ago, Willy was given just 6 months to live.
His surgical option for treatment would have left him without a right lower jaw and unable to eat or talk normally. The surgery would not have extended his life longer than a few months.
Willy decided to refuse surgery and come to CHIPSA all the way from Brazil.
His story inspired so many. His community in Brazil helped raise money for him to come to CHIPSA.
After three weeks of treatment, Willy saw his tumors begin to shrink dramatically. After 6 months his tumor reduced to scar tissue.
Willy returned to CHIPSA nearly 2 years after his initial arrival. His cancer had returned because immunotherapy wasn’t available to him in Brazil. This was at the start of the pandemic. Willy was responding well to treatments at CHIPSA. Unfortunately CHIPSA had to close briefly close due to the pandemic. Sadly, we received the report Willy passed away due to complications of Covid-19.
How does CHIPSA treat squamous cell carcinoma?
Patients with advanced SCC who have seen success at CHIPSA follow a variety of treatment protocols.
Gerson Therapy
The Gerson protocol is the foundational treatment for all patients at CHIPSA, including those with squamous cell carcinoma. Gerson Therapy is a diet-based immunological detoxification and nutrition protocol. It works to stimulate tissue repair and normal growth through the input of fresh and raw vegetable material. Fresh juice along with fruits and vegetables are amazing sources of micronutrients.
The diet includes raw and cooked foods in three vegan meals a day. SCC patients also drink anywhere from 6-12 fresh pressed juices a day.
IV Apatone Therapy
Patients with SCC receive IV infusions of our Apatone therapy. Apatone is a combination of intravenous vitamin C and K3 in 100:1 ratio.
The powerful combination can cause a form of cancer cell death called autoschizis. Studies have shown vitamin C to be cytotoxic against many cancers, including squamous cell carcinoma. Similarly, K3 is cytotoxic against tumors of breast, stomach, lung, colon, nasopharyngeal, cervix, liver, leukemia, and lymphoma cell lines.
Coley’s Toxins
SCC patients at CHIPSA also receive a therapy called Coley’s Toxins. Coley’s is comprised of a sterile (dead) mixture of gram-positive Streptococcus pyogenes and gram-negative Serratia marcescens bacteria. By introducing the dead bacteria into the body, the doctors can create an immune response without the risk of infection. Cancer cells are formed undetected by the immune system. The goal is to “unlock” the body’s immune system so that it can identify and kill the cancer cells.
SCC patients at CHIPSA will receive our new cutting-edge formulation of Coley’s toxins. Coley’s CPG is our proprietary blend of CPG-carrying agents that allow the immune system the best chance of creating an anti-tumor immune response. There are currently many clinical trials studying CPG in combination with checkpoint inhibitors. The belief is that Coley’s CPG turns a tumor from cold to hot, meaning a tumor that previously couldn’t be seen by the immune system is now recognized. Many people think a variation of this treatment could be a staple in all future cancer therapy.
CHIPSA has over 23 years of experience working with Coley’s toxins.
Note: CHIPSA is the only licensed hospital facility treating with the Coley’s Therapy toxins in North America.
IV Ozone Therapy
Ozone therapy is a powerful immune-stimulant known for its antiviral and antibacterial effects. It also protects cells against extra damage from chemotherapy. The doctors draw blood from patients and add ozone into it. It is then run through UV A, B, and C lights to further clean it of pathogens. The stimulation of the Ozone and UV light creates a vaccine-like immune response.
Dendritic Cell Therapy
Patients with squamous cell carcinoma may also benefit from our dendritic cell therapy, DC-Max. Scientists mature dendritic cells and re-infuse them into the patient. This process, in conjunction with a danger signal in the cancer cell, provides a great opportunity for the dendritic cell to present the tumor antigen to the t-cell and get a lasting remission. This personalized cellular product is unique to CHIPSA and not available anywhere else.
Insulin Potentiation Therapy (IPT) / Low-Dose Chemotherapy
IPT involves using very small doses of chemotherapy that more specifically target cancerous cells rather than infiltrating the entire body with the poisonous drug. The treatment begins with the patient lowering their blood-sugar levels by fasting and using insulin. This creates a mild state of hypoglycemia. At that point, the cancerous cells are so “hungry” that they become extremely receptive to anything that enters the body, including drugs. The patient is then given a small dose of chemotherapy which is infused with a glucose solution. The “starving” cancerous cells easily absorb the drug. This treatment allows chemotherapy to target malignant cells, destroy them more effectively, and leave the rest of the body in tact.
VG-5000 ™
VG-5000 builds upon the work of the acclaimed Russian immunologist Dr. Valentine Govallo. Dr. Govallo had over 40 years of experience in clinical immunology.
He is the author of 294 scientific papers and 19 scientific books. His vaccine was derived from full-term donated placentas which are normally thrown away after birth. He noticed that the immune system didn’t attack a placenta as it was being formed, and hypothesized that it would have the same defense mechanisms as a tumor.
In the 1970s, according to his book, he treated 35 patients with various solid tumor carcinomas (lung cancer, breast cancer, colorectal, melanoma) and reported a 65% 10-year survival rate.
Later generations of the vaccine were made and used in different parts of the world and recently other companies have made similar vaccines and defended mechanisms of action. VG-5000 stands for what is the 5th generation and most scientifically advanced version of his vaccine.
Why should you treat your squamous cell carcinoma at CHIPSA?
SCC patients are traveling all the way to CHIPSA to treat their cancer.
Our hospital offers a unique experience. Cancer is a complicated disease, and there are no easy answers for it. We certainly don’t have a miracle cure for the disease. But we do offer a chance for patients to try innovative treatments that often aren’t available anywhere else.
Our Healing Approach
Here at CHIPSA, we truly work to heal the body from the inside out. Our treatments are tailored towards nurturing the body with vitamins, nutrients, and detoxification therapies so that it can begin to heal from disease. The protocols at CHIPSA are not one-size-fits-all. We create a unique, individualized treatment plan for each and every patient based on their diagnosis and stage. We are also not afraid to change things up to see better results.
Our Community
Our patients often leave here saying they feel like family. We don’t treat you as just a “number”. You will receive undivided attention in a loving environment, along with opportunities to connect and spend time with other patients. This helps our patients to form a long-time support system. Such support can make a huge difference for patients who need the emotional stamina to keep going. You also have the opportunity to bring a companion along with you. This person will sleep in your room, eat your meals with you, learn about your treatments, and take part in their own seminars.
Our Commitment to Innovation
CHIPSA has been on the forefront of immunotherapy for over 40years. The field has been rapidly expanding over the last decade, as mainstream medical communities have realized the power the immune system holds. Our advisory board stays up to date on cutting-edge treatments.
Our Results
Many of our SCC patients who follow the at-home regimens CHIPSA recommends have seen their cancer disappear. While we aren’t able to help everyone our results give patients options that they didn’t have before.
If you or a loved one has been diagnosed with squamous cell carcinoma (SCC), call CHIPSA today for a FREE doctor’s consultation.